Research Interests:

Mosquito‐borne illnesses such malaria and dengue affect over 700 million people across the globe each year. Of these, over a million perish, and the vast majority of these deaths are concentrated in Africa. Despite the severity of this threat, our medical arsenal to counter mosquito‐borne illnesses is threadbare; and the complex pathophysiologies of these diseases, combined with a strict emphasis on affordability of the treatments, has significantly stifled the development of drugs against these ailments. To this end, my research group is employing emerging concepts in synthetic biology and bioengineering to attenuate the vectorial capacity of the
mosquito.